Adage Capital Partners
FMTX

Adage Capital Partners’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Adage Capital Partners’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-55,000
Closed -$1.54M – 1124
2021
Q1 		$1.54M Sell
55,000
-25,000
-31% -$902K ﹤0.01% 860
2020
Q4 		$2.79M Buy
+80,000
New +$3.48M 0.01% 730

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Adage Capital Partners's FMTX Position: Q2 2021 in Review

Adage Capital Partners sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q2 2021, closing a stake of 55,000 shares — an estimated $1.54M sold.

Adage Capital Partners first reported a position in FMTX in Q4 2020 and held it in 2 quarters. The position peaked at $2.79M in Q4 2020. 82 funds tracked by Wall St. Rank hold FMTX as of Q2 2021.

  • Adage Capital Partners reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Adage Capital Partners sold 55,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q2 2021, an estimated $1.54M.
  • Adage Capital Partners first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Adage Capital Partners's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $2.79M in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q2 2021.

Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.